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Abstract Lactobacillus paracasei has been demonstrated
to inhibit the growth of many pathogenic microbes such as
Streptococcus mutans, in vitro. However, its clinical
application remains unclear. Here, we examined whether a
novel probiotic L. paracasei GMNL-33 may reduce the
caries-associated salivary microbial counts in healthy
adults. Seventy-eight subjects (aged 20 to 26) had com-
pleted this double-blinded, randomized, placebo-controlled
study. A probiotic/test (n=42) and a control group (n=36)
took a L. paracasei GMNL-33 and a placebo oral tablet
three times per day for 2 weeks, respectively. Bacterial
counts of salivary S. mutans, lactobacilli, and salivary
buffer capacity were measured with chair-side kits at the
beginning (T1), the completion (T2) of medication, and
2 weeks after medication (T3). The results did not show
differences in the counts of S. mutans and lactobacilli
between probiotic and control groups at T1, T2, and T3.
Nevertheless, within the probiotic group, an interesting
probiotic effect was noticed. Between T1 and T2, no
inhibitory effect against S. mutans was observed. However,
a significant count reduction in the salivary S. mutans was
detected between T2 and T3 (p=0.016). Thus, a 2-week
period of medication via oral administration route may be
needed for L. paracasei GMNL-33 to be effective in the
probiotic action.
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Introduction
The definition of “probiotics” has been adopted by the
International Scientific Association and the World Health
Organization: “Live microorganisms, if administered in
adequate amounts, confer a health benefit on the host” [1].
Recently, a lot of studies focused on the effect of the
probiotic for oral health. Among previous human clinical
studies, Lactobacillus rhamnosus GG, ATCC 53103 (LGG)
and L. rhamnosus LC 705 [2], Lactobacillus reuteri [3–6],
and Bifidobacterium [7, 8] could inhibit the oral cariogenic
bacteria such as Streptococcus mutans.L G Ga n dL.
rhamnosus LC 705 could reduce the prevalence of yeast
counts in elder persons [9]. Lactobacillus salivarius TI
2711 could reduce Porphyromonas gingivalis counts [10].
L. reuteri could reduce gingivitis and plaque scores [11].
Weissella confusa CMU [12] and Streptococcus salivarius
K12 [13] could reduce halitosis in human study.
Lactobacillus paracasei isolated from healthy humans
showed antibacterial and anticandidal activities against oral
pathogens such as S. mutans, S. salivarius, Streptococcus
sanguis, Staphylococcus aureus, Actinomyces viscosus, P.
gingivalis, Candida albican, Candida tropicalis,a n d
Candida grabata [14]. The strongest antimicrobial activity
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rhamnosus, and L. salivarius isolated from the persons who
had chronic periodontitis or health periodontium [15].
Lactobacilli isolated from the caries-free instead of caries-
prone subjects had a significantly superior capacity to
suppress the growth of S. mutans; L. paracasei was one of
the Lactobacillus species with the maximum interference
activity against S. mutans in vitro [16].
According to these findings, a new product containing
probiotics L. paracasei aimed to reduce S. mutans was
designed. However, its ability for reduction of cariogenic
pathogens in human is unclear. A randomized human study
to evaluate the efficacy of this probiotic L. paracasei for
dental health is necessary.
The purpose of this study was to evaluate the efficacy
of the probiotic L. paracasei GMNL-33 for reducing
caries-associated salivary microbial counts in healthy
adults. S. mutans was determined to play a major role in
the initiation of caries lesions. Certain Lactobacillus
species were believed to have a part in the caries
progression. The salivary buffer capacity value would also
be detected as supplement indicator. The change of the
counts of these two microbials and the salivary buffer
capacity has been utilized in documented investigations
for caries risk evaluation. Thus, the two indicators would
be deemed adequate to assess the efficacy of the L.
paracasei for caries prevention. The null hypothesis was
that the probiotic L. paracasei GMNL-33 would not alter
the bacterial levels and salivary buffer capacity compared
with placebo controls.
Materials and methods
The study protocol was approved by the Institutional
Reviewing Broad (IRB 96-0311B) and Chang Gung Medical
Research Project (XMRPG 460021) at Human Investigation
Committee of Chang Gung Memorial Hospital and Chang
Gung University. Informed consent from each subject was
obtained prior to the clinical trial.
Participants
Eighty healthy volunteer subjects, aged 20–40 years,
were recruited for the study. Grouping by randomized,
double-blind method, there were 42 and 38 samples for
the probiotic and control group, respectively, at the
beginning of study. The inclusion criteria were healthy
adults without any prescribed medication. The exclusion
criteria were persons with smoking, systemic disease,
long-term use of antibiotics, or undergoing dental
treatment including orthodontic, periodontal, endodontic,
and prosthodontic treatment.
Study protocol and the intervention
The study was a randomized, double-blind, placebo-
controlled study with two parallel groups. The oral tablets
for the probiotic group and control group were randomized,
numbered from first to ninth according to a computer-
generated blocked, randomization list. For blinding pur-
poses, the packaging of both oral tablets was identical. A
total of 80 participants were randomized to receive one
package of oral tablets. The probiotic oral tablets, commer-
cial name as Dental-Lac, contained 11% xylitol and 4%
exact of L. paracasei GMNL-33 bacteria 3×10
8 cells/tablet
(1 g). The control tablets contained 11% xylitol without
probiotic strain. All of these oral tablets were prepared by
GenMont Biotech Incorporation, Taiwan. Subjects were
instructed to take one oral tablet and dissolve it in the
mouth slowly after meals three times a day for 2 weeks.
Throughout the study, they were supposed to turn in a diary
about how often they had taken the oral tablets.
The study consisted of two 2-week periods: a 2-week
intervention period (T1–T2) and a 2-week posttreatment
period (T2–T3). Bacterial counts of salivary S. mutans,
lactobacilli, and salivary buffer capacity were evaluated
with chair-side kits at baseline (T1), at the completion (T2)
of medication and 2 weeks after medication (T3).
The subjects could use toothbrushes, fluoride toothpaste,
and dental floss during the study period. The use of other
fluoride products, similar probiotic products, and other
medical oral rinse was forbidden. The participants were told
to brush their teeth twice a day.
Clinical examination
The subjects received an oral examination before the study
by two experienced dentists. The clinical examination was
conducted by using the oral mirror and Community
Periodontal Index probe under the natural light and
according to the WHO criteria (World Health Organiza-
tion, Oral Health Surveys Basic Method 4th ed.). The num-
ber of decayed/missing/filled teeth (DMFT) was recorded.
Saliva samples
Salivary microbials were collected three times at week 0, 2,
and 4 around noon time (11:00 a.m.–1:00 p.m.). The
subjects were told to refrain from eating and drinking for
2 h prior to the investigation.
Salivary counts of S. mutans were determined by using
the Dentocult SM Strip mutans® slides (Orion Diagnostica,
Finland). One of the examiners placed a bacitracin tablet in
the selective culture broth about 15 min before examina-
tion. Subjects chewed on a paraffin pellet for 1 min and
were instructed to swallow any excess saliva. They then
Clin Oral Invest (2011) 15:471–476 472pressed the rough surface of the strip against the saliva
remaining on the tongue. The strip that immersed with
saliva was placed in the selective culture broth. We
incubated the vial in an upright position at 37°C for 48 h
with the cap one quarter of a turn open. After incubation,
the presence of S. mutans was evidenced by dark blue to
light blue, raised colonies on the rough surface of the strip.
The density of S. mutans was obtained by comparing the
colony density on the test strip with the model chart: score
=0 for density less than or equal to 10
4CFU/ml, score = 1
for density between 10
4 and 10
5CFU/ml, score = 2 for
density between 10
5 and 10
6CFU/ml, and score=3 for
density greater than 10
6CFU/ml.
Salivary counts of lactobacilli were determined by
using the Dentocult LB Dip Slide® method (Orion
Diagnostica, Finland). We let the subjects chew on a
paraffin pellet for 2 min and collected the stimulated
saliva. Some drops of stimulated saliva were pipetted on
to both surfaces of the agar dip slides. We incubated the
vial in an upright position at 37°C for 4 days. The results
were presented as: score=0 for density equal to 10
3CFU/
ml, score = 1 for density equal to 10
4CFU/ml, score = 2
for density equal to 10
5CFU/ml, and score=3 for density
equal to 10
6CFU/ml.
There were three clinicians evaluating the test kits. The
agreement of the final measurement values of S. mutans
and lactobacilli with three clinicians was 0.79 to 0.88 and
0.69 to 0.85, respectively. The validity of these methods has
found to be good [17].
Salivary buffering capacity was determined by using the
Dentobuff® Strip method (Orion Diagnostica, Finland). A
drop of stimulated saliva was pipetted onto the pad, and the
result was read after 5 min. The color of this test pad was
compared with a standard color chart after 5 min to estimate
the final pH. The method grades stimulated saliva as low
(pH ≤4), intermediate (pH 4.5–5.5), or high (pH ≥6) buffer
capacity. The results were presented as: score=0 for low
pH, score=1 for intermediate pH, and score=2 for high pH.
Statistical analysis
Inter-group differences in salivary S. mutans counts,
salivary lactobacilli counts, and buffer capacity were
analyzed by Mann–Whitney U Test. Intra-group differences
in three stages of salivary S. mutans counts, salivary
lactobacilli counts, and salivary buffer capacity were
analyzed by the Wilcoxon signed-rank test. Fisher’s exact
test was applied to test the percentage of change in salivary
S. mutans counts, salivary lactobacilli counts, and salivary
buffer capacity. All the analyses were performed via
Statistical Package for Social Sciences (SPSS version 12.1
Inc., Chicago, IL, USA) software. The level of statistical
significance was set at p=0.05.
Results
There were 80 adult volunteers involved the clinical trial
and the number of investigated subjects were given in the
flow chart (Fig. 1). Two participants of the control group
dropped out during the study period. There were 42
subjects (21 female and 21 male, average age
21.0 ± 1.2 years old, DMFT 7.2 ± 5.2) in the probiotic
group and 36 subjects (21 female and 17 males, average
age 21.1 ± 2.1 years old, DMFT 5.4±3.4) in the control
group. The DMFT values between the two groups were
analyzed by Mann–Whitney U test. There were no
significant differences in the DMFT values between the
two groups (p=0.218).
The compliance of subjects was reported by themselves
through a record chart for oral tablets intake frequency. The
compliance results were presented as: “excellent” for eating
all tablets, “good” for only missing 1∼5 tablets, “moderate”
for missing 6∼10 tablets, and “poor” for missing more than
10 tablets. The excellent compliance was 41.33%, good
was 40.00%, moderate was 12.00%, and poor was 6.67%.
The comparison results of S. mutans counts, lactobacilli
counts, and buffer capacity were not significant between
probiotic and control groups at T1, T2, and T3. The data
was analyzed by Mann–Whitney U test. (Table 1)
Within the probiotic group, the S. mutans counts did not
change during T1–T2. However, the reduction of S. mutans
counts in the probiotic group was significantly different
during T2–T3 (p=0.016; Table 1). The lactobacilli counts
and buffer capacity of the probiotic group during T1–T2,
T2–T3, and T1–T3 were not significantly different. The
data was analyzed by Wilcoxon signed-rank test. (Table 1)
Within the control group, there were no significant
differences in the S. mutans counts, lactobacilli counts and
buffer capacity during T1–T2, T2–T3, and T1–T3. The data
was analyzed by Wilcoxon signed-rank test. (Table 1)
Randomization 
n=80 
Probiotic group 
n=42 
Control group 
n=38 
Discontinued 
￿  Nil 
Discontinued 
￿  Unwilling to take 
oral tablets (n=2) 
Probiotic group after 4 week 
n=42 
(21 female, 21 male) 
Control group after 4 week 
n=36 
(20 female, 16 male) 
Fig. 1 Flow chart showing the number of subjects in test and control
groups at the commencement and completion of the study
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lactobacilli counts, and buffer capacity was not signifi-
cantly different in comparison with the probiotic group
and control group during T1, T2, and T3. The data was
analyzed by Fisher’s exact test. Although we could not
find significant difference, the level of S. mutans counts
(>10
5CFU/ml, score 2 and 3) showed a trend for reduction
during T2–T3 and a slight increment during T1–T2
(Fig. 2).
Discussion
There were no significant differences in the S. mutans
counts, lactobacilli counts, and buffer capacity between the
probiotic and control groups at T1, T2, and T3. There were
several possible reasons suspected for the nonsignificant
difference in S. mutans counts between the probiotic and
control groups. First, there was the relatively small sample
size in our study. Second, the subjects only took L.
paracasei for 2 weeks in our study. In Nase’s study, the
intervention period of LGG was 7 months [2]. The 2-week
intervention period might be too short to express differ-
ences between two groups. Further L. paracasei GMNL-33
studies with extended intervention time and increased
subjects will be encouraged. In addition, the concentration
and vehicle type of L. paracasei would not be efficient
enough for reducing S. mutans rapidly.
Within the probiotic group, an interesting probiotic effect
was noticed. Between T1 and T2, no inhibitory effect
against S. mutans was observed. However, a significant
count reduction in the salivary S. mutans was detected
between T2 and T3 (p=0.016). It seemed likely that once
this probiotic had colonized into the oral cavity, it could
exert a beneficial effect which did not occur during a short-
term intervention. Thus, a 2-week period of medication via
oral administration route may be needed for L. paracasei
GMNL-33 to be effective in the probiotic action.
Table 1 The median of Streptococcus mutans counts, lactobacilli counts, and buffer capacity
Index Time Probiotic group median (range) Control group median (range) p value
a
Streptococcus mutans counts
T1 2 (0∼3) 1.5 (0∼3) 0.904
T2 2 (0∼3) 2 (0∼3) 0.875
T3 1 (0∼3) 2 (0∼3) 0.219
p value
b 0.405 0.806
p value
c 0.079 1.000
p value
d 0.016* 0.729
Lactobacilli counts
T1 0 (0∼3) 0 (0∼3) 0.967
T2 0 (0∼3) 0 (0∼3) 0.713
T3 0 (0∼3) 0 (0∼3) 0.730
p value
b 0.980 0.658
p value
c 0.154 0.666
p value
d 0.317 0.902
Buffer capacity
T1 2 (1∼2, 2) 2 (1∼2) 0.971
T2 2 (1∼2, 2) 2 (1∼2) 0.761
T3 2 (1∼2, 2) 2 (1∼2) 0.599
p value
b 0.593 0.257
p value
c 0.796 0.366
p value
d 0.739 1.000
Score of Streptococcus mutans counts: score=0 for density less than or equal to 10
4 CFU/ml, score=1 for density between 10
4 and 10
5 CFU/ml,
score=2 for density between 10
5 and 10
6 CFU/ml, and score=3 for density greater than 10
6 CFU/ml. Score of lactobacilli counts: score=0 for density
equal to 10
3 CFU/ml, score=1 for density equal to 10
4 CFU/ml, score=2 for density equal to 10
5 CFU/ml, and score=3 for density equal to 10
6 CFU/ml.
Score of buffer capacity=0 for low pH, score=1 for intermediate pH, and score=2 for high pH.
T1: baseline (week 0), T2: the completion of medication (week 2), T3: 2 weeks after medication (week 4)
*p<0.05, **p<0.01
aDifference between probiotic and control group; to analyze the data, Mann–Whitney U test was used
bDifference between T1 and T2; to analyze the data, Wilcoxon signed-rank test was used
cDifference between T1 and T3; to analyze the data, Wilcoxon signed-rank test was used
dDifference between T2 and T3; to analyze the data, Wilcoxon signed-rank test was used
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the probiotic group was significantly reduced only between
T2 and T3 (p=0.016). The S. mutans lowering effect of
probiotics was more pronounced in the posttreatment
period (T2-T3) rather than the intervention period (T1-
T2). The result was comparable to the studies of Ahola [18]
and Nikawa [6]. Ahola et al. [18] examined whether the
short-term consumption of cheese containing LGG and L.
rhamnosus LC 705 would diminish caries-associated
salivary microbial counts in young adults. The results
showed S. mutans counts were significantly reduced in the
probiotic group, yet only during the posttreatment period.
Nikawa et al. [6] examined the effect of short-term yogurt
consumption with L. reuteri on the oral carriage of S.
mutans. The results suggested that L. reuteri in yogurt
reduced the S. mutans counts for up to 2 weeks after
discontinuing the consumption. Both short-term probiotic
interventions seemed to enhance the inhibitory effect
against S. mutans after the intervention. Although we used
different species of probiotic bacteria, the posttreatment
effect was similar. But the mechanism of this posttreatment
effect was not clear. Further studies for investigating the
mechanism of the posttreatment effects of the probiotics
would be needed.
Daily consumption of lactobacilli might lead to a transient
(albeit permanent) colonizationofthese bacteria[19]. Busscher
et al. [20]a n dP e t t ie ta l .[ 21] were unable to detect an oral
colonization of lactobacilli after probiotic yogurt consump-
tion. By contrast, Meurman et al. [22] reported that LGG was
detected for up to 2 weeks after discontinued consumption of
probiotic yogurt. Another bacteriocin producer S. salivarius
K12 was used as a probiotic targeting the oral cavity. Horz et
al. [23] monitored its dispersal and persistence in an oral
environment by using real-time quantitative polymerase chain
reaction. K12 could be detected at the mucosal membrane for
1 to 3 weeks yet with steadily decreasing tendency after
1 week. Thus probiotics may have the potential to control oral
bacterial infections only when the uptake is repeated
frequently.
We did not find statistically significant differences in the
lactobacilli counts within and between probiotic versus
control groups. However, there was a tendency for the
probiotic intervention to increase the count levels of lactoba-
cilli. Montalto investigated whether the oral administration of
lactobacilli could change the salivary counts of these bacteria
[24]. It was found that the oral administration of probiotics
significantly increased salivary counts of lactobacilli. In
another study, the salivary lactobacilli counts also increased
after intake of the probiotic-containing cheese [18].
It should be noted that there were differences among
various lactobacilli with regard to their abilities to cause
dental caries. Some Lactobacillus species were identified in
deep caries dentin and were related to dental caries
progression. For example, Lactobacillus acidophilus and
Lactobacillus casei Shirota might be strong agents in dental
caries progression for their adhesive ability to dental
surface [25]. However, it had been suggested that not all
strains of Lactobacillus spp. had a caries-inducing effect
[3]. In this study, the oral tablet contained L. paracasei
extract that were not considered cariogenic. The elevation
of count levels in lactobacilli could be reasonably consid-
ered as its well colonization in oral cavity under interven-
tion instead of increasing caries risk [24].
Along with L. paracasei, the well-documented Lactoba-
cillus GG was not considered cariogenic and had been
shown to exert inhibitory activity against Streptococcus
sobrinus at pH values below 5 [26]. The investigators also
found that Lactobacillus GG did not ferment sucrose and
thus did not promote caries. In addition, in vitro studies had
shown that other lactobacilli, such as Lactobacillus fermen-
tum and L. salivarius, had an inhibiting effect on the growth
of S. mutans [27] and P. gingivalis [10]. All the lactobacilli
except Lactobacillus jensenii produced bacteriocin against
at least one of the indicator organisms. The ability of
Lactobacillus spp. to protect their host against certain
diseases by inhibiting the growth of potential pathogens
was evident [15].
Salivary buffer capacity was not changed in the current
L. paracasei GMNL-33 study. It was not changed on other
comparable probiotic studies either [18].
Fig. 2 Percentage (95% confidence interval) of participants with high
Streptococcus mutans counts (≥105CFU/ml, score 2 and 3) in
probiotic (n=42) and control (n=36) groups at baseline (T1), the
completion of medication (T2), and 2 weeks after medication (T3).
(Fisher’s exact test revealed p>0.05 (NS))
Clin Oral Invest (2011) 15:471–476 475In conclusion, the results of this study indicate that a 2-week
period of medication at least may be needed for L. paracasei
GMNL-33 via oral administration route to become effective
in the probiotic action. And short-term probiotic intervention
seemed to enhance its inhibitory effect against S. mutans after
the intervention. Further studies for investigating the mecha-
nism of the posttreatment effects of the probiotics would be
needed.
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